ReP USP - Resultado da busca

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial (2012)

Hueb, Whady Armindo; Gersh, Bernard J; Rezende, Paulo C; Garzillo, Cibele L; Lima, Eduardo G; Vieira, Ricardo D'Oliveira; Garcia, Rosa Maria Rahmi; Favarato, Desiderio; Segre, Carlos Alexandre W; Pereira, Alexandre C; Soares, Paulo Rogério; Ribeiro, Expedito; Lemos, Pedro; Perin, Marco A; Strunz, Célia C; Dallan, Luís Alberto Oliveira; Jatene, Fábio Biscegli; Stolf, Noedir Antônio Groppo; Hueb, Alexandre C; Dias, Ricardo; Gaiotto, Fabio A; Costa, Leandro Menezes A da; Oikawa, Fernando Teiichi C; Melo, Rodrigo Morel V de; Serrano, Carlos V; Ávila, Luiz Francisco R de; Villa, Alexandre V; Parga Filho, José Rodrigues; Nomura, César; Ramires, José A F; Kalil Filho, Roberto

Source: BMC Cardiovascular Disorders. Unidades: FM, MAE

Subjects: BIOMARCADORES, PROGNÓSTICO, REVASCULARIZAÇÃO MIOCÁRDICA, RESSONÂNCIA MAGNÉTICA NUCLEAR (DIAGNÓSTICO), NECROSE

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
HUEB, Whady Armindo et al. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. BMC Cardiovascular Disorders, v. 12, p. 6 , 2012Tradução . . Disponível em: https://doi.org/10.1186/1471-2261-12-65. Acesso em: 19 nov. 2024.
APA
Hueb, W. A., Gersh, B. J., Rezende, P. C., Garzillo, C. L., Lima, E. G., Vieira, R. D. 'O., et al. (2012). Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. BMC Cardiovascular Disorders, 12, 6 . doi:10.1186/1471-2261-12-65
NLM
Hueb WA, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD'O, Garcia RMR, Favarato D, Segre CAW, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LAO, Jatene FB, Stolf NAG, Hueb AC, Dias R, Gaiotto FA, Costa LMA da, Oikawa FTC, Melo RMV de, Serrano CV, Ávila LFR de, Villa AV, Parga Filho JR, Nomura C, Ramires JAF, Kalil Filho R. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial [Internet]. BMC Cardiovascular Disorders. 2012 ; 126 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.1186/1471-2261-12-65
Vancouver
Hueb WA, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD'O, Garcia RMR, Favarato D, Segre CAW, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LAO, Jatene FB, Stolf NAG, Hueb AC, Dias R, Gaiotto FA, Costa LMA da, Oikawa FTC, Melo RMV de, Serrano CV, Ávila LFR de, Villa AV, Parga Filho JR, Nomura C, Ramires JAF, Kalil Filho R. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial [Internet]. BMC Cardiovascular Disorders. 2012 ; 126 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.1186/1471-2261-12-65

USP Schools

ReP

Filtros

Authors